Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG4CR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,981
Award facts
- Contract value 100% obligated
- $37,981.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $37,981.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 7.5 mg/0.5 mL pens on February 4, 2026, with completion expected by February 5, 2026. The awardee, headquartered in Conshohocken, Pennsylvania, is a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems. This delivery order was competitively awarded with no set-aside designation and represents a task order execution under the broader pharmaceutical supply framework maintained by the Defense Logistics Agency.
This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. The contract encompasses a wide range of prescription medications, specialty pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen's federal contract portfolio demonstrates its significant role as a critical vendor supporting military treatment facilities, veterans' healthcare programs, and other federal medical institutions through both individual delivery orders and the broader IDC framework.
Quick answers
Who was awarded contract SPE2DR26FG4CR?
SPE2DR26FG4CR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FG4CR worth?
The government has obligated $37,981 on SPE2DR26FG4CR.
Is contract SPE2DR26FG4CR an order under another contract?
Yes. SPE2DR26FG4CR is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG4CR competed?
The extent of competition for SPE2DR26FG4CR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award